AIDS Vaccine Science for Busy Advocates – RV144: Building on a breakthrough

A one-page document describing RV144, the first AIDS vaccine trial to show protection against HIV in humans, and plans to further this research.

AIDS Vaccine Science for Busy Advocates – Passive Immunization: An important piece of the puzzle

A one-page document describing passive immunization, the transfer of pre-made antibodies, and its potential for HIV prevention.

HIV Vaccines: Key messages

This is a three-page document providing main points surrounding vaccine research. For a shorter one-page version of this, click here.

Pre-Exposure Prophylaxis: An introductory factsheet

This introductory 2-page document defines PrEP, reviews the scientific evidence to date, and outlines key research, regulatory and advocacy issues going forward. This factsheet is part of a series on emerging HIV prevention strategies.

Treatment as Prevention: An introductory factsheet

This introductory 2-page document defines treatment as prevention, reviews the scientific evidence behind it, and outlines implementation advocacy priorities. The factsheet is part of a series on emerging HIV prevention strategies.

Microbicides for HIV Prevention: An introductory factsheet

This introductory 2-page document defines microbicides and reviews the state of research on some leading candidates.

Multipurpose Prevention Technologies (MPTs): An introductory factsheet

This introductory 2-page document makes the case for why women need prevention options that protect them against multiple risks—HIV, STIs and/or pregnancy—and discusses the products that are being studied for this purpose. The factsheet is part of a series on emerging HIV prevention strategies.

PrEP Primer (Chinese)

This document, developed by 2012 AVAC Advocacy Fellow Cai Lingping, provides background information on pre-exposure prophylaxis, reviews the evidence base and planned trials, and discusses key issues for Chinese advocates. It explores implementation challenges and the funding landscape for continued research.

Letter to Ambassador Goosby from Kenyan Civil Society

This letter on behalf of civil society organizations working in HIV and AIDS in Kenya offers recommendations for PEPFAR’s Kenya Country Operational Plan (COP) in 2013. The letter includes calls for increased investment in HIV treatment options and enhanced participation of CSO-selected civil society groups in every stage of the COP drafting process.

Advocate’s Guide to Statistical Terms

Simple one-page resource explaining terms like “statistical significance,” “p-value,” “confidence interval” and other concepts used to describe and interpret the results of clinical trials.